oxaloacetic acid has been researched along with Ataxia with Lactic Acidosis 2 in 1 studies
Oxaloacetic Acid: A dicarboxylic acid ketone that is an important metabolic intermediate of the CITRIC ACID CYCLE. It can be converted to ASPARTIC ACID by ASPARTATE TRANSAMINASE.
oxaloacetic acid : An oxodicarboxylic acid that is succinic acid bearing a single oxo group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Marin-Valencia, I | 1 |
Roe, CR | 1 |
Pascual, JM | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Post Study Continuation of C7 for G1D[NCT02018302] | 0 participants | Expanded Access | No longer available | ||||
Treatment Development of Triheptanoin for Glucose Transporter Type I Deficiency[NCT02021526] | Phase 1/Phase 2 | 0 participants (Actual) | Interventional | 2015-12-31 | Withdrawn (stopped due to NIH funding resulted in new clinical trial) | ||
The Glucose Transporter Type I Deficiency (G1D) Registry[NCT02013583] | 750 participants (Anticipated) | Observational [Patient Registry] | 2013-12-31 | Recruiting | |||
Clinical Trial of Citric Acid Cycle Stimulation in Energy-deficiency States: Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D) (NMTUT 2010B)[NCT02018315] | Phase 1 | 14 participants (Actual) | Interventional | 2012-01-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Magnetic Resonance Imaging (MRI) used to calculate brain metabolic rate. Brain metabolic rate compared before oil ingestion (Baseline), 90 minutes after oil ingestion, and after 3 months of daily oil ingestion in each participant. Triheptanoin metabolism may lead to increased oxygen consumption only while the brain undergoes a reduction of ictogenesis. We hypothesize that when ictogenesis is abolished by triheptanoin or absent at baseline, triheptanoin exerts little or no effect on CMR02. (NCT02018315)
Timeframe: 3 months
Intervention | Participants (Count of Participants) |
---|---|
Experimental: Triheptanoin | 5 |
Visual analysis of EEG recording to determine the fraction of spike-range within the area of recording. (NCT02018315)
Timeframe: 1 day
Intervention | Participants (Count of Participants) |
---|---|
Experimental: Triheptanoin | 13 |
1 review available for oxaloacetic acid and Ataxia with Lactic Acidosis 2
Article | Year |
---|---|
Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis.
Topics: Animals; Carbon; Humans; Oxaloacetic Acid; Phenotype; Pyruvate Carboxylase; Pyruvate Carboxylase Def | 2010 |
Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis.
Topics: Animals; Carbon; Humans; Oxaloacetic Acid; Phenotype; Pyruvate Carboxylase; Pyruvate Carboxylase Def | 2010 |
Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis.
Topics: Animals; Carbon; Humans; Oxaloacetic Acid; Phenotype; Pyruvate Carboxylase; Pyruvate Carboxylase Def | 2010 |
Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis.
Topics: Animals; Carbon; Humans; Oxaloacetic Acid; Phenotype; Pyruvate Carboxylase; Pyruvate Carboxylase Def | 2010 |
Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis.
Topics: Animals; Carbon; Humans; Oxaloacetic Acid; Phenotype; Pyruvate Carboxylase; Pyruvate Carboxylase Def | 2010 |
Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis.
Topics: Animals; Carbon; Humans; Oxaloacetic Acid; Phenotype; Pyruvate Carboxylase; Pyruvate Carboxylase Def | 2010 |
Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis.
Topics: Animals; Carbon; Humans; Oxaloacetic Acid; Phenotype; Pyruvate Carboxylase; Pyruvate Carboxylase Def | 2010 |
Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis.
Topics: Animals; Carbon; Humans; Oxaloacetic Acid; Phenotype; Pyruvate Carboxylase; Pyruvate Carboxylase Def | 2010 |
Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis.
Topics: Animals; Carbon; Humans; Oxaloacetic Acid; Phenotype; Pyruvate Carboxylase; Pyruvate Carboxylase Def | 2010 |
Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis.
Topics: Animals; Carbon; Humans; Oxaloacetic Acid; Phenotype; Pyruvate Carboxylase; Pyruvate Carboxylase Def | 2010 |
Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis.
Topics: Animals; Carbon; Humans; Oxaloacetic Acid; Phenotype; Pyruvate Carboxylase; Pyruvate Carboxylase Def | 2010 |
Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis.
Topics: Animals; Carbon; Humans; Oxaloacetic Acid; Phenotype; Pyruvate Carboxylase; Pyruvate Carboxylase Def | 2010 |
Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis.
Topics: Animals; Carbon; Humans; Oxaloacetic Acid; Phenotype; Pyruvate Carboxylase; Pyruvate Carboxylase Def | 2010 |
Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis.
Topics: Animals; Carbon; Humans; Oxaloacetic Acid; Phenotype; Pyruvate Carboxylase; Pyruvate Carboxylase Def | 2010 |
Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis.
Topics: Animals; Carbon; Humans; Oxaloacetic Acid; Phenotype; Pyruvate Carboxylase; Pyruvate Carboxylase Def | 2010 |
Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis.
Topics: Animals; Carbon; Humans; Oxaloacetic Acid; Phenotype; Pyruvate Carboxylase; Pyruvate Carboxylase Def | 2010 |